Anson Funds Management LP 13D and 13G filings for SELLAS Life Sciences Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:34 am Purchase | 2025-12-31 | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Anson Funds Management LP | 7,481,178 4.900% | 1,448,240 (+24.01%) | Filing |
| 2025-11-14 3:15 pm Purchase | 2025-09-30 | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Anson Funds Management LP | 6,032,938 5.700% | 806,990 (+15.44%) | Filing |
| 2025-08-14 9:43 pm Sale | 2025-06-30 | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Anson Funds Management LP | 5,225,948 4.900% | -2,353,147 (-31.05%) | Filing |
| 2025-05-15 4:59 pm Purchase | 2025-03-31 | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Anson Funds Management LP | 7,579,095 8.300% | 7,579,095 (New Position) | Filing |